Cancer

Featured

Indiaflag

Ethical concerns with cervical cancer screening trials in India

Recently, the Indian Journal of Medical Ethics published an article by Dr. Eric Suba regarding ethical and scientific controversies about large-scale longitudinal randomized trials of various…

Laos

Innovative partnership connects kids, vaccine in Laos

Guest contributor Monica Graham is a communications officer with our Vaccine Access and Delivery Program. Thanks to an innovative partnership between Microsoft employees and PATH, thousands of children in Laos no longer face the possibility of severe, lifelong brain injury … Continue reading » ; ; ; ;Related StoriesCervical cancer vaccines: will our best hopes be realized?Social entrepreneurs: here are two rules to ensure impactNew infographic: 9 ways to improve child survival ;

WHO

Two shots of HPV vaccine against cervical cancer enough, says WHO

New vaccines against the virus which triggers most cervical cancers will protect young girls after two doses, rather than the three in the current schedule, enabling GAVI to reach more in the developing world where most cases occurReaching more girls in developing countries with the HPV vaccine that can prevent most cases of cervical cancer has just become more feasible. The World Health Organisation’s expert advisory group has said that two shots of vaccine against human papillomavirus (HPV) is going to be sufficiently protective for girls, instead of the three-doses currently recommended, as long as they have it before they reach the age of 15.Three shots of vaccine – either Merck’s Gardasil or GSK’s Cervarix – have been incorporated into immunisation schedules in affluent countries. But there is enough evidence now, according to the WHO’s SAGE committee – strategic advisory group of experts – on immunisation, to rule that two shots will do the job. SAGE reiterated the importance of providing human papillomavirus immunization to girls as early as necessary, i.e.

Latest

HPV Vaccine Effective Among Women With HIV, Study Shows

New York Times: Cancer Vaccine Proves Effective in HIV Patients “Vaccines against cervical cancer work well even in sexually active women with HIV, a new study has found. It also found that women who already have one or two strains of the cancer-causing virus can be protected against others…” (McNeil, 4/21).


Ethical concerns with cervical cancer screening trials in India

Indiaflag

Recently, the Indian Journal of Medical Ethics published an article by Dr. Eric Suba regarding ethical and scientific controversies about large-scale longitudinal randomized trials of various…


Innovative partnership connects kids, vaccine in Laos

Laos

Guest contributor Monica Graham is a communications officer with our Vaccine Access and Delivery Program. Thanks to an innovative partnership between Microsoft employees and PATH, thousands of children in Laos no longer face the possibility of severe, lifelong brain injury … Continue reading » ; ; ; ;Related StoriesCervical cancer vaccines: will our best hopes be realized?Social entrepreneurs: here are two rules to ensure impactNew infographic: 9 ways to improve child survival ;


IHP news 267: Happy Easter!

Dear Colleagues, It’s Friday, so my coffee consumption is going through the roof. The Christians among you probably have other things to do this weekend, so we’ll keep this intro short. The atheists, agnostics, Muslims, Buddhists, Hindus and new agers among you will surely not mind. As for the “Socialist” who has his very own religion, global health, maybe this weekend is a good time to chant his planetary manifesto together with his beloved ones.   In this week’s guest editorial, Agnes Nanyonjo ( from the Malaria Consortium Uganda, and also an EV 2012) provides some of her impressions of the 2014 Geneva Health Forum, focusing mostly on day 1 of the three-day conference


CDC Foundation, George W. Bush Institute Partner To Address Global Cervical Cancer

“The CDC Foundation and the George W. Bush Institute [Wednesday] announced a new partnership to help stem the tide of cervical cancer in low- and middle-income countries based on a $3.6 million grant from the Bill & Melinda Gates Foundation,” according to a CDC Foundation press release. In an article written for the foundation’s blog,…More


2 HPV Vaccine Shots, Instead Of 3, Sufficient For Cancer Protection, WHO Says

The Guardian: Two shots of HPV vaccine against cervical cancer enough, says WHO “Reaching a greater number of girls in developing countries with the HPV vaccine that can prevent most cases of cervical cancer has just become more feasible. The World Health Organization’s expert advisory group said that two shots of vaccine against human papillomavirus…More


Two shots of HPV vaccine against cervical cancer enough, says WHO

WHO

New vaccines against the virus which triggers most cervical cancers will protect young girls after two doses, rather than the three in the current schedule, enabling GAVI to reach more in the developing world where most cases occurReaching more girls in developing countries with the HPV vaccine that can prevent most cases of cervical cancer has just become more feasible. The World Health Organisation’s expert advisory group has said that two shots of vaccine against human papillomavirus (HPV) is going to be sufficiently protective for girls, instead of the three-doses currently recommended, as long as they have it before they reach the age of 15.Three shots of vaccine – either Merck’s Gardasil or GSK’s Cervarix – have been incorporated into immunisation schedules in affluent countries. But there is enough evidence now, according to the WHO’s SAGE committee – strategic advisory group of experts – on immunisation, to rule that two shots will do the job. SAGE reiterated the importance of providing human papillomavirus immunization to girls as early as necessary, i.e.


Challenges to effective cancer control in China, India, and Russia

china flag

“Collectively, China, India, and Russia account for around 40% of the world’s population, experience 46% of all new cancers worldwide, and account for 52% of…


Learning From HIV To Treat, Prevent HPV, Other Cancers

The Hill: HPV may be the new HIV Elizabeth Chabner Thompson, founder of BFFL Co. “In May, I will be traveling with a group of physicians to Botswana for a conference sponsored by the Ministry of Health and several other organizations in hopes to inspire discussion around cancer care in Botswana and to work toward…More


The Daily Impact: Emergency measures taken to prevent Ebola spread in West Africa

April 11, 2014 The historic ebola outbreak that started in Guinea continues as aid groups are taking emergency steps to prevent its spread. From AFP: The tropical bug is thought to have killed more than 110 people in Guinea and Liberia since January, with suspected cases reported in Mali and Sierra Leone and aid workers warning that vital hygiene products could run out. The Geneva-based World Health Organization (WHO) announced emergency training for 70 people who would fan out across the Guinean capital Conakry to track people who have had close contact with Ebola patients. The UN agency is also setting up a special alert and response operation centre within the Guinean health ministry and training staff at Guinea’s main hospital and other health facilities. The organisation has described west Africa’s first Ebola outbreak as one of the most challenging since the virus emerged in 1976 in what is now the Democratic Republic of Congo